AI offers tremendous benefits but creates new challenges for licensing and research integrity that medical publishers must address. In this MAPS podcast episode, we will discuss the opportunities and challenges of AI in scientific publishing and considerations for medical education.
In this On-Demand webinar, we will provide attendees with perspectives on these important questions from industry leaders across functions, including Commercial, Marketing, Market Access and R&D, and practical advice on how to master the art of collaboration to improve cohesion for collective success.
In this On-Demand webinar, we will explore data analytics can be effectively integrated into Medical Affairs workflows to address key challenges and opportunities in the field.
Join experts from Enago Life Sciences to learn best practices for navigating the balance between efficiency and authority in expedited publishing.
As Med Ed teams adopt new tech, it’s key to know how physicians prefer learning. This article shares 2025 MAPS tips with simple “do THIS, not THAT” strategies.
Medical Affairs gathers insights from both internal and external sources, disseminating them cross-functionally to support a range of applications, including evidence generation planning, content development, HCP engagement, customer targeting, and strategy development. This article highlights key learnings from the ‘Omnichannel Insights – Driving Engagement Strategy’ forum.
This article summarizes insights from a 2025 MAPS Roundtable where Medical Affairs leaders discussed emerging trends in digital engagement, focusing on the rise of Digital Opinion Leaders (DOLs) and strategies for Healthcare Professional (HCP) influence mapping. The conversation highlighted how innovative approaches are reshaping disease awareness and stakeholder relationships.
Is Bluesky the new Twitter (X) for academic research conversations? Learn how Medical Affairs teams can maximize the opportunity of this new platform.
In what is certainly a new high or a new low for this podcast, we explore how to calculate the “Kardashian Index” of your KOLs and scientific leaders.
Johnson & Johnson’s Medical Affairs team is transforming strategy with data-driven insights, moving beyond traditional approaches to identify key opinion leaders, improve advisory board diversity, and enhance patient journey mapping. With H1’s analytics, they are shifting from quantity to quality in engagements, advancing health equity, and leveraging AI for smarter decision-making.